Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry and of Neuroscience
John H. Krystal, M.D.
John H. Krystal, M.D.
Chair, Department of Psychiatry,
Chief of Psychiatry, Yale-New Haven Hospital
Director: NIAAA Center for the Translational Neuroscience of Alcoholism
Director, Clinical Neuroscience Division, VA National Center for PTSD
Scientific Council Member (Joined 2003)
2006, 2000 Distinguished Investigator Grant
1997 Independent Investigator Grant
Dr. Krystal is an expert on the neurobiology and treatment of schizophrenia, post-traumatic stress disorder, and alcoholism. In these areas, he has linked experimental psychopharmacology, neuroimaging, and genetics to identify disturbances in the function of brain circuits, particularly those involving glutamate and GABA that might be targeted in the development of new treatments. He developed the use of ketamine as a probe of glutamate receptor function in brain and behavior disorders. This work contributed to the development of mGluR2/3 agonist treatments for schizophrenia and riluzole and NMDA receptor antagonist treatments for depression and alcoholism.
President of the American College of Neuropsychopharmacology, Dr. Krystal has completed residency at Yale.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.